Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 9—September 2007

Dispatch

New Clinicoepidemiologic Profile of Cutaneous Leishmaniasis, Morocco

Mohamed Rhajaoui*1, Abedelmajeed Nasereddin†1Comments to Author , Hajiba Fellah*, Kifaya Azmi†, Fatima Amarir*, Amer Al-Jawabreh†, Suheir Ereqat†, Joseph Planer‡, and Ziad Abdeen†
Author affiliations: *Institut National d’Hygiène, Rabat, Morocco; †Al-Quds University, East Jerusalem, Palestine; ‡Manchester College, North Manchester, Indiana, USA;

Main Article

Figure 2

Comparison between endonuclease BsuRI digestion patterns of internal transcribed spacer 1–PCR products from clinical samples and reference Leishmania strains. Clinical samples, lanes 1–6: lane 1, Boulmane; lane 2, Ouarzazate; lanes 3–6, Sidi Kacem. Reference strains, lanes 7–9: lane 7, L. tropica (MHOM/SU/1974/SAF-K27); lane 8, L. major (MHOM/TM/1973/5ASKH); lane 9, L. infantum (MHOM/TN/1980/IPT1). MW, DNA molecular weight marker in base pairs (bp).

Figure 2. Comparison between endonuclease BsuRI digestion patterns of internal transcribed spacer 1–PCR products from clinical samples and reference Leishmania strains. Clinical samples, lanes 1–6: lane 1, Boulmane; lane 2, Ouarzazate; lanes 3–6, Sidi Kacem. Reference strains, lanes 7–9: lane 7, L. tropica (MHOM/SU/1974/SAF-K27); lane 8, L. major (MHOM/TM/1973/5ASKH); lane 9, L. infantum (MHOM/TN/1980/IPT1). MW, DNA molecular weight marker in base pairs (bp).

Main Article

1These authors contributed equally to this article.

TOP